Patient characteristics
N = 54 . | No. . | Percent . |
|---|---|---|
| Age, median, y (range) | 52 (29-71) | — |
| Male | 37 | 68.5 |
| Prior chemotherapy | 54 | 100 |
| VAD | 50 | 93 |
| No. of cycles, median (range) | 4 (2-10) | — |
| More than one regimen | 26 | 48 |
| XRT | 4 | 7.8 |
| Response from last therapy at time of auto HCT | ||
| CR | 6 | 11 |
| PR | 22 | 41 |
| Untreated relapse | 7 | 13 |
| Refractory | 19 | 35 |
| B2M, median, μg/mL (range) | 1.94 (0.6-5.8) | — |
| B2M, greater than 2.5 μg/mL | 16/50 | 32 |
| Days Dx to auto, median (range) | 282 (163-3629) | — |
N = 54 . | No. . | Percent . |
|---|---|---|
| Age, median, y (range) | 52 (29-71) | — |
| Male | 37 | 68.5 |
| Prior chemotherapy | 54 | 100 |
| VAD | 50 | 93 |
| No. of cycles, median (range) | 4 (2-10) | — |
| More than one regimen | 26 | 48 |
| XRT | 4 | 7.8 |
| Response from last therapy at time of auto HCT | ||
| CR | 6 | 11 |
| PR | 22 | 41 |
| Untreated relapse | 7 | 13 |
| Refractory | 19 | 35 |
| B2M, median, μg/mL (range) | 1.94 (0.6-5.8) | — |
| B2M, greater than 2.5 μg/mL | 16/50 | 32 |
| Days Dx to auto, median (range) | 282 (163-3629) | — |
VAD indicates vincristine, adriamycin, dexamethasone; XRT, radiation therapy; CR, complete remission; PR, partial remission; B2M, beta-2 microglobulin; Dx, diagnosis; and —, not applicable.